RxDoctor Payments Data

Barbara Levin, MD

Family Medicine · Vonore, TNNPI 1922041409

Payments from drug & device makers

$1,293in general payments, 2019–2025

Across 80 payments — averaging $16.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$388
  • Novo Nordisk$319
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$124
  • Exact Sciences$78
  • Amgen$71
  • Braeburn Inc.$50
  • plus $262 from 11 others

What the payments were for

  • Food & beverage$1,293100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,293 in reported general payments places this provider in the 60th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$2,813
Medicare patients
58
Services billed
255

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban76$55,832
Trelegy ElliptaFluticasone/Umeclidin/Vilanter41$30,187
VraylarCariprazine Hcl16$24,176
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl201$23,017
OzempicSemaglutide24$22,138
EntrestoSacubitril/Valsartan20$15,758
TrulicityDulaglutide15$14,553
FarxigaDapagliflozin Propanediol19$13,183
LinzessLinaclotide16$8,916
Spiriva HandihalerTiotropium Bromide11$5,921
BrilintaTicagrelor12$5,914
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen233$5,080
Aripiprazole27$4,424
Humulin R U-500 KwikpenInsulin Regular, Human11$3,912
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen159$3,438

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$14$55,83276 claims
AbbVieVraylar, Linzess$388$33,09232 claims
Novo NordiskOzempic$319$22,13824 claims
AstraZenecaFarxiga, Brilinta$24$19,09731 claims
Lilly USA, LLCTrulicity$27$14,55315 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Vonore

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →